Legislator Case Law & Legislation
812.21 HMGLPTHLATER CH

Art. 15 Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Marketing authorisation on the basis of a notification

TPA; Chapter 2 Medicinal Products
Open official source Full Act (141 Articles) Machine-readable Markdown (.md)

Art. 15 TPA · Marketing authorisation on the basis of a notification

The following may be placed on the market following notification to the Agency: a. complementary medicines without indications, the active substances of which are included in lists for specific therapy approaches; b. other medicinal products or groups of medicinal products for which, due to their low risk potential, a simplified marketing authorisation proves to be disproportionate.

The Agency shall draw up the lists referred to in paragraph 1 letter a. It shall determine the medicinal products or groups of medicinal products referred to in paragraph 1 letter b and regulate the notification procedure.

← Art. 14a TPA Federal Act of 15 December 2000 on Medicinal Products and Medical Devices (TPA) - Purpose Art. 16 TPA →

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →

Court Decisions Applying This Provision (1)

VPB 08-1321-6731 (Art. 15 LPTh)
Swiss Approval of Foreign-Approved Products
This article is mentioned in relation to the Council of States' decision to supplement it, allowing Swissmedic to require only a simple notification obligation for hospital preparations, though Swissmedic already possesses this competence.